Literature DB >> 16282337

Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma.

Ying-Wei Lin1, Rebecca A Nichols, John J Letterio, Peter D Aplan.   

Abstract

NOTCH1 is frequently mutated in human precursor T-cell lymphoblastic leukemia/lymphoma (pre-T LBL). In the current study, we found that 13 of 19 cell lines and 29 of 49 primary tumors from SCL/LMO1, OLIG2/LMO1, OLIG2, LMO1, NUP98/HOXD13, and p27(-/-)/SMAD3(+/-) mice had Notch1 mutations in either the heterodimerization (HD) or the glutamic acid/serine/threonine (PEST) domain but not both. Thymocytes from clinically healthy SCL/LMO1 mice aged 5 weeks did not have Notch1 mutations, whereas thymocytes from clinically healthy SCL/LMO1 mice aged 8 to 12 weeks did have Notch1 mutations and formed tumors upon transplantation into nude mice. Remarkably, all of the HD domain mutations that we identified were single-base substitutions, whereas all of the PEST domain mutations were insertions or deletions, half of which mapped to 1 of 2 mutational "hot spots." Taken together, these findings indicate that Notch1 mutations are very frequent events that are acquired relatively early in the process of leukemic transformation and are important for leukemic cell growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282337      PMCID: PMC1414627          DOI: 10.1182/blood-2005-07-3013

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

2.  An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

Authors:  P D Aplan; C A Jones; D S Chervinsky; X Zhao; M Ellsworth; C Wu; E A McGuire; K W Gross
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

3.  Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice.

Authors:  D S Chervinsky; D H Lam; X F Zhao; M P Melman; P D Aplan
Journal:  Leukemia       Date:  2001-01       Impact factor: 11.528

4.  scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.

Authors:  D S Chervinsky; D H Lam; M P Melman; K W Gross; P D Aplan
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

5.  Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.

Authors:  D S Chervinsky; X F Zhao; D H Lam; M Ellsworth; K W Gross; P D Aplan
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells.

Authors:  Seiji Hitoshi; Tania Alexson; Vincent Tropepe; Dorit Donoviel; Andrew J Elia; Jeffrey S Nye; Ronald A Conlon; Tak W Mak; Alan Bernstein; Derek van der Kooy
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

7.  Notch1 expression in early lymphopoiesis influences B versus T lineage determination.

Authors:  J C Pui; D Allman; L Xu; S DeRocco; F G Karnell; S Bakkour; J Y Lee; T Kadesch; R R Hardy; J C Aster; W S Pear
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

8.  Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma.

Authors:  E A McGuire; C E Rintoul; G M Sclar; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

9.  TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.

Authors:  L W Ellisen; J Bird; D C West; A L Soreng; T C Reynolds; S D Smith; J Sklar
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  The SCL gene product: a positive regulator of erythroid differentiation.

Authors:  P D Aplan; K Nakahara; S H Orkin; I R Kirsch
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  55 in total

1.  Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.

Authors:  Todd D Ashworth; Warren S Pear; Mark Y Chiang; Stephen C Blacklow; Jérôme Mastio; Lanwei Xu; Michelle Kelliher; Philippe Kastner; Susan Chan; Jon C Aster
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

Review 2.  The double-edged sword of Notch signaling in cancer.

Authors:  Andrew P South; Raymond J Cho; Jon C Aster
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

3.  Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.

Authors:  Sarah H Beachy; Masahiro Onozawa; Yang Jo Chung; Chris Slape; Sven Bilke; Princy Francis; Marbin Pineda; Robert L Walker; Paul Meltzer; Peter D Aplan
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

4.  Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1.

Authors:  Mark Y Chiang; Mina L Xu; Gavin Histen; Olga Shestova; Monideepa Roy; Yunsun Nam; Stephen C Blacklow; David B Sacks; Warren S Pear; Jon C Aster
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

5.  Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia.

Authors:  Steven M Chan; Andrew P Weng; Robert Tibshirani; Jon C Aster; Paul J Utz
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

6.  Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.

Authors:  Sarah H Beachy; Masahiro Onozawa; Deborah Silverman; Yang Jo Chung; Mariela Martinez Rivera; Peter D Aplan
Journal:  Exp Hematol       Date:  2013-02-19       Impact factor: 3.084

Review 7.  The Notch signaling pathway as a mediator of tumor survival.

Authors:  Kathleen M Capaccione; Sharon R Pine
Journal:  Carcinogenesis       Date:  2013-04-12       Impact factor: 4.944

8.  K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to gamma-secretase inhibitors.

Authors:  Thomas Kindler; Melanie G Cornejo; Claudia Scholl; Jianing Liu; Dena S Leeman; J Erika Haydu; Stefan Fröhling; Benjamin H Lee; D Gary Gilliland
Journal:  Blood       Date:  2008-07-28       Impact factor: 22.113

9.  Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.

Authors:  Catherine Hartzell; Olga Ksionda; Ed Lemmens; Kristen Coakley; Ming Yang; Monique Dail; Richard C Harvey; Christopher Govern; Jeroen Bakker; Tineke L Lenstra; Kristin Ammon; Anne Boeter; Stuart S Winter; Mignon Loh; Kevin Shannon; Arup K Chakraborty; Matthias Wabl; Jeroen P Roose
Journal:  Sci Signal       Date:  2013-03-26       Impact factor: 8.192

10.  Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia.

Authors:  Mark Y Chiang; Lanwei Xu; Olga Shestova; Gavin Histen; Sarah L'heureux; Candice Romany; M Eden Childs; Phyllis A Gimotty; Jon C Aster; Warren S Pear
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.